Omar Ford

Omar Ford is MD+DI's managing editor. You can reach him at [email protected].

RenalytixAI Hits Milestone with Break Through Designation

The company is developing an AI-based technology that could help diagnose kidney disease.

3M to Acquire Acelity for $6.7B

The proposed merger comes just a week after 3M posted disappointing quarterly earnings and announced it would layoff 2,000 employees.

LivaNova Disappoints with 1Q19 Earnings

The London-based company’s Neuromodulation business brought earnings down because more patients were trying Epidiolex, a new drug approved for the treatment of seizures associated with two rare and severe forms of epilepsy.

2019 Medical Design Excellence Awards Finalists

See the innovative medical products that rose above the rest as finalists in the medtech industry's premier awards program.

Digital Health Plays Larger Role in MDEA for 2019

Welcome to the world of digital health! Jurors debated to see which devices and apps were the most innovative for the Medical Design Excellence Awards.

2 of Edwards' Pediatric Catheters Face Class I Recall

The Irvine, CA-based company’s Miller Balloon Atrioseptostomy Catheter and Fogarty Dilation Atrioseptostomy Catheter are in a Class I recall because of the possibility of difficulty in balloon deflation after deployment.

Physician’s Device Puts a New Spin on Ultrasound

CoapTech has secured a clearance from FDA for the PUMA-G System platform, a device that enables ultrasound-based placement of percutaneous gastrostomy feeding tubes.

Cardiac Dimensions Spot on with FMR Treatment

The Kirkland, WA-based company presented new data confirming significant reduction in regurgitant volume directly after implantation of the Carillon Mitral Contour System.

How POC Diagnostics Are Becoming the Norm

Point-of-Care diagnostics are more common place as consumer demand is increasing in healthcare.

Ivantis and Glaukos Clash in 1st Head-to-Head MIGS Trial

The COMPARE study showed that 73% of patients receiving the Ivantis’ Hydrus Microstent achieved at least a 20% reduction in IOP while on fewer medications, compared to 47% of the two iStent eyes.

3M to Lay Off 2,000 Employees after Weak 1Q19 Earnings

The Maplewood, MN-based company posted “disappointing” 1Q19 earnings and lowered its 2019 outlook.

AliveCor’s New Indications Help Consumers Understand Their Hearts

The Mountain View, CA-based company now has FDA clearance for its KardiaMobile ECG to detect BradyCardia and TachyCardia.

Boston Sci Ends TAVR ‘Duopoly’ Held by Medtronic and Edwards

FDA’s approval of the Marlborough, MA-based company’s Lotus Edge Valve could represent a paradigm shift in the transcatheter aortic valve replacement market.